201 related articles for article (PubMed ID: 30007159)
1. Sema3E/PlexinD1 inhibition is a therapeutic strategy for improving cerebral perfusion and restoring functional loss after stroke in aged rats.
Zhou YF; Li PC; Wu JH; Haslam JA; Mao L; Xia YP; He QW; Wang XX; Lei H; Lan XL; Miao QR; Yue ZY; Li YN; Hu B
Neurobiol Aging; 2018 Oct; 70():102-116. PubMed ID: 30007159
[TBL] [Abstract][Full Text] [Related]
2. Sema3E/PlexinD1 signaling inhibits postischemic angiogenesis by regulating endothelial DLL4 and filopodia formation in a rat model of ischemic stroke.
Zhou YF; Chen AQ; Wu JH; Mao L; Xia YP; Jin HJ; He QW; Miao QR; Yue ZY; Liu XL; Huang M; Li YN; Hu B
FASEB J; 2019 Apr; 33(4):4947-4961. PubMed ID: 30653356
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis.
Moriya J; Minamino T; Tateno K; Okada S; Uemura A; Shimizu I; Yokoyama M; Nojima A; Okada M; Koga H; Komuro I
Circ Res; 2010 Feb; 106(2):391-8. PubMed ID: 19940264
[TBL] [Abstract][Full Text] [Related]
4. Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice.
Fukushima Y; Okada M; Kataoka H; Hirashima M; Yoshida Y; Mann F; Gomi F; Nishida K; Nishikawa S; Uemura A
J Clin Invest; 2011 May; 121(5):1974-85. PubMed ID: 21505259
[TBL] [Abstract][Full Text] [Related]
5. Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development.
Chauvet S; Cohen S; Yoshida Y; Fekrane L; Livet J; Gayet O; Segu L; Buhot MC; Jessell TM; Henderson CE; Mann F
Neuron; 2007 Dec; 56(5):807-22. PubMed ID: 18054858
[TBL] [Abstract][Full Text] [Related]
6. Neuronal chemorepellent Semaphorin 3E inhibits human airway smooth muscle cell proliferation and migration.
Movassagh H; Shan L; Halayko AJ; Roth M; Tamm M; Chakir J; Gounni AS
J Allergy Clin Immunol; 2014 Feb; 133(2):560-7. PubMed ID: 23932461
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin 3E promote Schwann cell proliferation and migration.
Shen M; Chen Y; Tang W; Ming M; Tian Y; Ding F; Wu H; Ji Y
Exp Cell Res; 2022 Mar; 412(2):113019. PubMed ID: 35085549
[TBL] [Abstract][Full Text] [Related]
8. Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.
Casazza A; Kigel B; Maione F; Capparuccia L; Kessler O; Giraudo E; Mazzone M; Neufeld G; Tamagnone L
EMBO Mol Med; 2012 Mar; 4(3):234-50. PubMed ID: 22247010
[TBL] [Abstract][Full Text] [Related]
9. New functions of Semaphorin 3E and its receptor PlexinD1 during developing and adult hippocampal formation.
Mata A; Gil V; Pérez-Clausell J; Dasilva M; González-Calixto MC; Soriano E; García-Verdugo JM; Sanchez-Vives MV; Del Río JA
Sci Rep; 2018 Jan; 8(1):1381. PubMed ID: 29358640
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-149-5p regulates blood-brain barrier permeability after transient middle cerebral artery occlusion in rats by targeting S1PR2 of pericytes.
Wan Y; Jin HJ; Zhu YY; Fang Z; Mao L; He Q; Xia YP; Li M; Li Y; Chen X; Hu B
FASEB J; 2018 Jun; 32(6):3133-3148. PubMed ID: 29401609
[TBL] [Abstract][Full Text] [Related]
11. Insulin-Like Growth Factor (IGF)-I Modulates Endothelial Blood-Brain Barrier Function in Ischemic Middle-Aged Female Rats.
Bake S; Okoreeh AK; Alaniz RC; Sohrabji F
Endocrinology; 2016 Jan; 157(1):61-9. PubMed ID: 26556536
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways.
Aghajanian H; Choi C; Ho VC; Gupta M; Singh MK; Epstein JA
J Biol Chem; 2014 Jun; 289(26):17971-9. PubMed ID: 24825896
[TBL] [Abstract][Full Text] [Related]
13. Sema4D/PlexinB1 inhibition ameliorates blood-brain barrier damage and improves outcome after stroke in rats.
Zhou YF; Li YN; Jin HJ; Wu JH; He QW; Wang XX; Lei H; Hu B
FASEB J; 2018 Apr; 32(4):2181-2196. PubMed ID: 29242274
[TBL] [Abstract][Full Text] [Related]
14. Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling.
Beck H; Acker T; Püschel AW; Fujisawa H; Carmeliet P; Plate KH
J Neuropathol Exp Neurol; 2002 Apr; 61(4):339-50. PubMed ID: 11939589
[TBL] [Abstract][Full Text] [Related]
15. Semaphorin3E-induced inflammation contributes to insulin resistance in dietary obesity.
Shimizu I; Yoshida Y; Moriya J; Nojima A; Uemura A; Kobayashi Y; Minamino T
Cell Metab; 2013 Oct; 18(4):491-504. PubMed ID: 24093674
[TBL] [Abstract][Full Text] [Related]
16. Sustained up-regulation of semaphorin 3A, Neuropilin1, and doublecortin expression in ischemic mouse brain during long-term recovery.
Hou ST; Keklikian A; Slinn J; O'Hare M; Jiang SX; Aylsworth A
Biochem Biophys Res Commun; 2008 Feb; 367(1):109-15. PubMed ID: 18162177
[TBL] [Abstract][Full Text] [Related]
17. Vascular Sema3E-Plexin-D1 Signaling Reactivation Promotes Post-stroke Recovery through VEGF Downregulation in Mice.
Yu R; Kim NS; Li Y; Jeong JY; Park SJ; Zhou B; Oh WJ
Transl Stroke Res; 2022 Feb; 13(1):142-159. PubMed ID: 33978913
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of semaphorin 3E for the treatment of choroidal neovascularization.
Suda K; Guo C; Oishi A; Ikeda S; Uemura A; Yoshimura N
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4700-6. PubMed ID: 24985470
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stromal Cells Promote Retinal Vascular Repair by Modulating Sema3E and IL-17A in a Model of Ischemic Retinopathy.
Noueihed B; Rivera JC; Dabouz R; Abram P; Omri S; Lahaie I; Chemtob S
Front Cell Dev Biol; 2021; 9():630645. PubMed ID: 33553187
[TBL] [Abstract][Full Text] [Related]
20. Semaphorin3E-PlexinD1 signaling in coronary artery and lymphatic vessel development with clinical implications in myocardial recovery.
Maruyama K; Naemura K; Arima Y; Uchijima Y; Nagao H; Yoshihara K; Singh MK; Uemura A; Matsuzaki F; Yoshida Y; Kurihara Y; Miyagawa-Tomita S; Kurihara H
iScience; 2021 Apr; 24(4):102305. PubMed ID: 33870127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
